Patents Examined by Christopher A. Flory
  • Patent number: 9999763
    Abstract: Apparatus for neuromuscular electrical stimulation and methods for anchoring the same are provided. The apparatus may include an elongated member having one or more electrodes disposed at the distal region of the elongated member and at least one fixation element disposed at the distal region of the elongated member. The fixation element may be shaped and sized to be deployed between tissue layers, such as muscle layers, without damaging the tissue layers so as to secure the one or more electrodes in or adjacent to a desired anatomical site within a patient. An additional fixation element may be disposed at the distal region of the elongated member so that tissue, such as a muscle, may be sandwiched between the fixation elements without damaging the tissue.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: June 19, 2018
    Assignee: Mainstay Medical Limited
    Inventors: Jason Alan Shiroff, Henry Thomas Demorett, Prashant Brijmohansingh Rawat, Johannes Petrus Heemels, Peter Andrew Crosby
  • Patent number: 9993642
    Abstract: In various embodiments, non-invasive methods to induce motor control in a mammal subject to spinal cord or other neurological injuries are provided. In some embodiments the methods involve administering transcutaneous electrical spinal cord stimulation (tSCS) to the mammal at a frequency and intensity that induces locomotor activity.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 12, 2018
    Assignee: The Regents of the University of California
    Inventors: Yury Gerasimenko, Victor Reggie Edgerton, Roland R. Roy, Daniel C. Lu
  • Patent number: 9993644
    Abstract: An exemplary fitting system 1) directs an EAS system to concurrently apply acoustic stimulation to a patient by way of a loudspeaker and electrical stimulation to the patient by way of an electrode located within a cochlea of the patient, 2) determines an interactive effect that the electrical stimulation has on the acoustic stimulation, 3) directs, if the fitting facility determines that the interactive effect is suppressive, the EAS system to use a first stimulation strategy that steers a current field produced by stimulation of the electrode away from intracochlear acoustic responders within the patient that are associated with the acoustic stimulation, and 4) directs, if the fitting facility does not determine that the interactive effect is suppressive, the EAS system to use a second stimulation strategy that steers the current field produced by the stimulation of the electrode towards the intracochlear acoustic responders.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: June 12, 2018
    Assignee: Advanced Bionics AG
    Inventors: Kanthaiah Koka, Leonid M. Litvak, Abhijit Kulkarni
  • Patent number: 9993587
    Abstract: A system for facilitating fluid connection between cannulae and a blood pump. The system includes a cannula having a distal end adapted to be in fluid communication with the circulatory system and a proximal end configured to couple to an inlet of the blood pump. Further included is a tunneling device configured to be inserted into a body of a patient to direct the proximal end of the cannula adjacent to the inlet and including a second connecting structure. Further included is a plug which has a first plug part and a second plug part. The first plug part includes a second connecting structure, the first and second connecting structures being selectively engageable. The second plug part is configured to be inserted in the proximal end of the cannula. The first and second plug parts are selectively disengageable to allow in situ disconnection between the cannula and tunneling device.
    Type: Grant
    Filed: May 7, 2015
    Date of Patent: June 12, 2018
    Assignee: CircuLite, Inc.
    Inventors: Robert C. Farnan, Brad Aurilia, Cesar Gomez
  • Patent number: 9986922
    Abstract: A pulse wave detection method includes obtaining an image obtained by photographing a subject with an imaging device, extracting intensities representative of signal components of a specific frequency band for respective wavelength components among signals of a plurality of wavelength components included in the image, calculating, using the intensities extracted for the respective wavelength components, a weight coefficient by which a signal is multiplied when the signals are calculated between the wavelength components to minimize an arithmetic value of the signal components in the specific frequency band after multiplication, multiplying at least one of the signals of the respective wavelength components by the weight coefficient, performing arithmetic operation on the signals between the wavelength components after multiplication by the weight coefficient, and detecting pulse waves of the subject using a signal after the arithmetic operation.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: June 5, 2018
    Assignee: FUJITSU LIMITED
    Inventors: Daisuke Uchida, Masato Sakata, Hidenori Sekiguchi, Akihiro Inomata
  • Patent number: 9981137
    Abstract: An implantable medical device that includes electrical circuitry for providing a therapy to a patient. The device also includes a housing forming an inner chamber that is adapted for receiving, at least a portion of the electrical circuitry. The device further includes a thermally conductive material that is configured to disperse heat from a first portion of the implantable medical device that is located in proximity to a heat generating component of the electrical circuitry, to a second portion of the implantable medical device that is not located in proximity to said heat generating component. The thermally conductive material is a discrete component separate from the electrical circuitry and the housing.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: May 29, 2018
    Assignee: Nuvectra Corporation
    Inventor: Jay H Eiger
  • Patent number: 9974609
    Abstract: A medical device is disclosed for delivering energy to a body lumen. The device includes an elongate member including a proximal portion and a distal portion adapted for insertion into a body lumen; and an energy delivery device disposed adjacent the distal portion of the elongate member, the energy delivery device including at least one elongate electrode arm, wherein the elongate electrode arm is configured to transition between a first configuration and a second configuration different than the first configuration. The at least one elongate electrode arm includes an active region configured to contact and deliver energy to the body lumen. When the elongate electrode arm is in the first configuration, at least a portion of the active region of the elongate electrode arm extends radially inward toward a longitudinal axis of the energy delivery device.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: May 22, 2018
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Andrew K. Hollett, Craig McGreevy
  • Patent number: 9974952
    Abstract: Sound processor housings, sound processors and systems including sound processors are disclosed. The housings include a main portion with a power supply receptacle, a seal and power supply receptacle cover. The seal may include a deflectable portion and define a material-free region into which the deflectable portion deflects in response to the application of radial force by the power supply receptacle cover.
    Type: Grant
    Filed: November 19, 2011
    Date of Patent: May 22, 2018
    Assignee: Advanced Bionics AG
    Inventors: James P. Goodman, Adam Smith
  • Patent number: 9974946
    Abstract: An intravascular catheter is positionable within a blood vessel for use in transvenous stimulation of targets external to the wall of the blood vessel. The catheter includes a catheter body, a support at the distal end of the catheter body, and a plurality of electrodes carried by the support. At least a portion of the support being inflatable within the blood vessel to bias at least a portion of the plurality of electrodes into contact with the blood vessel wall.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: May 22, 2018
    Inventors: Richard A Glenn, Stephen C Purcell
  • Patent number: 9968778
    Abstract: A system for designing a therapy or for treating a gastrointestinal disorder or a condition associated with excess weight in a subject comprising at least one electrode configured to be implanted within a body of the patient and placed at a vagus nerve, the electrode also configured to apply therapy to the vagus nerve upon application of a therapy cycle to the electrode; an implantable neuroregulator for placement in the body of the patient beneath the skin layer, the implantable neuroregulator being configured to generate a therapy cycle, wherein the therapy cycle comprises an on time during which an electrical signal is delivered, the electrical signal comprising: a) a set of pulses applied at a first selected frequency of about 150-10,000 Hz, wherein each pulse of the set of pulses has a pulse width of at least 0.01 milliseconds and less than the period of the first selected frequency.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: May 15, 2018
    Assignee: ReShape Lifesciences Inc.
    Inventors: Katherine S. Tweden, Jonathan J. Waataja, Adrianus P. Donders, Mark B. Knudson
  • Patent number: 9973867
    Abstract: Cochlear implant headpieces with improved moisture resistance.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: May 15, 2018
    Assignee: Advanced Bionics AG
    Inventor: Manish Vaishya
  • Patent number: 9968776
    Abstract: Example implantable cardiac electrotherapy leads are disclosed herein. In an example, a lead may include a plurality of cable conductors within an insulating jacket. A first one and a second one of the conductors include a proximal end at a proximal end of the jacket, the second conductor extends to at least the distal end of the jacket, and the first conductor includes a distal end at an intermediate location between the proximal end and the distal end of the jacket. The lead may also include a crimp connector connected to the first one of the cable conductors at the intermediate location, as well as a conductive element that may be connected to the crimp connector. A number of conductors along the proximal portion of the jacket may be greater than a number of conductors along at least a segment of the distal portion of the jacket.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: May 15, 2018
    Assignee: PACESETTER, INC.
    Inventors: Michael Childers, Keith Victorine, Steven R. Conger, Alexander Farr
  • Patent number: 9968258
    Abstract: Devices for use in fluorescence or luminescence lifetime imaging include a chip featuring an imaging region that includes a photodetector for receiving optical signals, and a time-to-digital converter for providing digital phase output based on the received optical signals.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: May 15, 2018
    Assignee: Tufts University
    Inventors: Jian Guo, Sameer Sonkusale
  • Patent number: 9962475
    Abstract: Disclosed herein are heart pumps that can include a catheter body and an impeller coupled with a distal end of the catheter body. The impeller can include a tip that is resealable or that includes a resealable member. The heart pump can also include a diffuser disposed between the distal end of the catheter body and the impeller, wherein the diffuser includes a flow directing surface.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: May 8, 2018
    Assignees: TC1 LLC, THE PENN STATE RESEARCH FOUNDATION
    Inventors: Robert L. Campbell, Jeremy J. Koncoski, Thomas M. Mallison, Mark W. McBride, Daniel Metrey, Eric C. Myer, Kevin J. Powell, Adam Roslund, Daniel A. Walters, William James Repka, Phyllis Yuen
  • Patent number: 9956402
    Abstract: Radiopaque markers represent that a lead is suitable for a particular medical procedure such as a magnetic resonance image scan and are added to the lead or related device. The markers may be added after implantation of the lead in various ways including suturing, gluing, crimping, or clamping a radiopaque tag to the lead or to the device. The markers may be added by placing a radiopaque coil about the lead, and the radiopaque coil may radially contract against the lead to obtain a fixed position. The markers may be added by placing a polymer structure onto the lead where the polymer structure includes a radiopaque marker within it. The polymer structure may include a cylindrical aperture that contracts against the lead to fix the position of the structure. The polymer structure may form a lead anchor that includes suture wings that can be sutured to the lead.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: May 1, 2018
    Assignee: MEDTRONIC, INC.
    Inventors: James M. Olsen, Michael R. Klardie, Richard T. Stone, Chad Q. Cai, Spencer M. Bondhus, Mark J. Conroy, Timothy R. Abraham, Bruce R. Mehdizadeh, Michael J. Kern, Jay K. Lahti
  • Patent number: 9955891
    Abstract: Systems and methods are provided to detect subwaveforms of an ECG waveform. Electrical impulses are detected between at least one pair of electrodes of two or more electrodes placed proximate to a beating heart and are converted to an ECG waveform for each heartbeat of the beating heart using the detector. One or more subwaveforms within P, Q, R, S, T, U, and J waveforms of the ECG waveform for each heartbeat or in an interval between the P, Q, R, S, T, U, and J waveforms that represent the depolarization or repolarization of an anatomically distinct portion of muscle tissue of the beating heart are detected using a signal processor. A processed ECG waveform that includes the one or more subwaveforms for each heartbeat is produced using the signal processor. The processed ECG waveform is received from the signal processor is displayed using a display device.
    Type: Grant
    Filed: May 10, 2016
    Date of Patent: May 1, 2018
    Inventor: Guangren Chen
  • Patent number: 9955892
    Abstract: A method of targeting fibrosis or autonomic nerve tissue for ablation in a subject is provided. The method includes performing at least one EGM analysis of a plurality of recorded atrial EGMs for a tissue in a region suspected of having fibrosis or autonomic nerve tissue. With regard to targeting fibrosis for ablation, the method includes determining one or more correlations of at least one AF EGM characteristic to a region having fibrosis from the plurality of recorded atrial EGMs for the tissue and determining whether the tissue contains dense fibrosis that would preclude effective ablation of the analysis region of the tissue. With regard to targeting autonomic nerve for ablation, the method includes determining whether one or more significant changes in EGM characteristics with autonomic blockade exist that would indicate the need to perform ablation of the analysis region of the tissue.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: May 1, 2018
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Rlshi Arora, Jason Ng
  • Patent number: 9956417
    Abstract: A technique for identifying lead-related conditions, such as insulation breaches and/or externalization of lead conductors, includes analyzing characteristics of electrical signals generated on one or more electrode sensing vectors of the lead by a test signal to determine whether a lead-related condition exists. The characteristics of the electrical signals induced on the lead by the test signal may be significantly different on a lead having an insulation breach or externalized conductor than on a lead not having such lead-related conditions. As such, the implantable medical device may be subject to a known test signal and analyze the signals on the lead to detect lead-related conditions.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: May 1, 2018
    Assignee: Medtronic, Inc.
    Inventors: ShaileshKumar V. Musley, Bruce D. Gunderson, Walter H. Olson, Jennifer P. Miller
  • Patent number: 9950158
    Abstract: An implantable cardiac rhythm management (CRM) system for directing stimulation energy toward a target tissue and away from unwanted tissues for providing an appropriate stimulation is provided by the present invention. The implantable cardiac rhythm management (CRM) system includes an implantable lead. The implantable lead includes a lead body and an electrically insulating member. The lead body includes at least one electrode extending substantially around the lead body. The electrically insulating member defines at least one window. At least one insulating member includes a protruding portion configured to urge at least one electrode toward the target tissue.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: April 24, 2018
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Kyle True, Brian Soltis
  • Patent number: 9936920
    Abstract: Self measurements of physiological parameters such as blood pressure are prone to errors and artifacts since they are often not done according to established and standardized protocols i.e., such that predetermined conditions for a reliable measurement are not met. To determine whether the predetermined conditions for a reliable measurement are met one or more physiological and environmental sensors are used to determine a measurement context. The obtained sensor data is compared with predetermined thresholds to determine whether the context allows a reliable self test. In case the predetermined conditions are not met based on the obtained sensor data instructions are given to guide the subject that wants to do a self test.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: April 10, 2018
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventor: Jens Muehlsteff